Feb 8 (Reuters) - CytRx Corp CYTR.O :
* Secures $40 million long-term loan facility
* Proceeds from first $25 million tranche will be used for
pre-commercialization and manufacturing activities for aldoxorubicin
* Says has received the first $25 million of financing under the loan and
security agreement
* Second tranche of up to $15 million will be available on or before December
31 if co says positive data from phase 3 clinical trial of aldoxorubicin
* Source text for Eikon urn:newsml:reuters.com:*:nPn7qF8Wc
* Further company coverage CYTR.O ((Bengaluru Newsroom; +1 646 223 8780))